Antithrombotic therapy in atrial fibrillation

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 579S-589S

  Laupacis, Andreas ^a   Albers, Gregory ^a   Dalen, James ^a   Dunn, Marvin I ^a   Jacobson, Alan K ^a   Singer, Daniel E ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DIPYRIDAMOLE; INDOBUFEN; WARFARIN;

ANTICOAGULATION; BRAIN HEMORRHAGE; CARDIOVERSION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MONITORING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0031728632     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5_Supplement.579S     Document Type: Conference Paper

References (10)

1. Feinberg WM, Blackshear JL, Laupacis A, et al. The prevalence of atrial fibrillation: analysis and implications. Arch Intern Med 1995; 155:469-473
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22:983-988
3. Lake FR, McCall MG, Cullen KJ, et al. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med 1989; 19:321-326
4. Phillips SJ, Whisnant JP, O'Fallon WM, et al. Prevalence of cardiovascular disease and diabetes in residents of Rochester, Minnesota. Mayo Clin Proc 1990; 65:344-359
5. Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study). Am J Cardiol 1994; 74:238-241
6. EAFT Study Group. European Atrial Fibrillation Trial: secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and a recent transient ischaemic attack or minor ischaemic stroke. Lancet 1993; 342:1255-1262
7. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial. Lancet 1996; 348:633-638
8. SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998; 279:1273-1277
9. Morocutti C, Amabile G, Fattapposta F, et al, for the Studio Italiano Fibrillazione Atriale Investigators. Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. Stroke 1997; 28:1015-1021
10. Diener H, Cunha L, Forbes C, et al. European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the prevention of stroke. J Neurol Sci 1996; 143:1-13